Search Within

Anas Younes

Formats
  1. Meeting Abstract (153)
  2. Journal Article (136)
  3. Book Section (13)
  4. Book Whole (4)
  5. Editorial (4)
  6. Review (4)
  7. Conference Paper (2)
  8. Research Letter (2)
  9. Correspondence (1)
  10. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (320)
  2. Department of Medicine (320)
  3. Executive Committee, Center for Hematologic Malignancies (320)
  4. Hematologic Malignancies, Division of (320)
  5. Lymphoma (320)
  6. Hematology-Oncology Fellows (98)

More Groups

People
  1. Andrew Zelenetz (89)
  2. Connie Batlevi (81)
  3. David Straus (74)
  4. Matthew Matasar (68)
  5. Anita Kumar (67)
  6. Paul Hamlin (67)

More People

Years
  1. 2024 (3)
  2. 2023 (7)
  3. 2022 (11)
  4. 2021 (13)
  5. 2020 (26)
  6. 2019 (53)

More Years

Publications
  1. Blood (91)
  2. Journal of Clinical Oncology (25)
  3. Hematological Oncology (22)
  4. Haematologica (16)
  5. British Journal of Haematology (13)
  6. Cancer Research (10)

More Publications

Publishers
  1. American Society of Hematology (99)
  2. American Society of Clinical Oncology (27)
  3. Wiley Blackwell (25)
  4. Nature Publishing Group (19)
  5. Springer (17)
  6. American Association for Cancer Research (16)

More Publishers

Results (320)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic profiling combining DNA and RNA analysis of 112 formalin-fixed paraffin-embedded diffuse large B cell lymphoma specimens identifies a high frequency of clinically relevant genomic alterations
    Meeting Abstract

    Intlekofer, A. M.; Hilden, P.; Seshan, V. E.; Copeland, A. R.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed advanced stage Hodgkin lymphoma: Long term outcomes
    Meeting Abstract

    Connors, J. M.; Ansell, S.; Park, S. I.; Fanale, M. A.; Younes, A.
    Blood (2014)

    Fulltext@MSK | Save
  • Biomarker analysis in a phase Ib study combining ibrutinib with R-CHOP in patients with CD20-positive B-cell non-Hodgkin lymphoma (NHL)
    Meeting Abstract

    Chaturvedi, S.; Schaffer, M.; Davis, C.; Aquino, R.; Stepanchick, E.; Oki, Y.; Fourneau, N.; Younes, A.; Balasubramanian, S.
    Blood (2014)

    Fulltext@MSK | Save
  • Identification of actionable genomic alterations across different lymphoma histologies using a comprehensive next generation genomic sequencing clinical assay
    Meeting Abstract

    Batlevi, C.; Moskowitz, C. H.; Zelenetz, A. D.; Horwitz, S. M.; Palomba, L.; Gerecitano, J. F.; Copeland, A. R.; Hamlin, P.; Matasar, M. J.; Sauter, C. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Precision therapy for lymphoma - Current state and future directions
    Journal Article

    Intlekofer, A. M.; Younes, A.
    Nature Reviews Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Paclitaxel, topotecan and rituximab: Long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
    Journal Article

    Westin, J. R.; McLaughlin, P.; Romaguera, J.; Hagemeister, F. B.; Pro, B.; Dang, N. H.; Samaniego, F.; Rodriguez, M. A.; Fayad, L.; Oki, Y.; more...
    British Journal of Haematology (2014)

    Fulltext@MSK | Save
  • Improvements in treatments for Hodgkin lymphoma over a 50-year period lead to fewer second malignancies
    Meeting Abstract

    Dabaja, B.; Shihadeh, F.; Rodriguez, M.; Etzel, C.; Liang, F.; Shirvani, S. M.; Ballas, L. K.; Allen, P.; Fanale, M.; Wogan, C.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: A non-randomised, phase 1b study
    Journal Article

    Younes, A.; Thieblemont, C.; Morschhauser, F.; Flinn, I.; Friedberg, J. W.; Amorim, S.; Hivert, B.; Westin, J.; Vermeulen, J.; Bandyopadhyay, N.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save
  • Diffuse large B cell lymphoma: Using pathologic and molecular biomarkers to define subgroups for novel therapy
    Journal Article

    Carbone, A.; Gloghini, A.; Kwong, Y. L.; Younes, A.
    Annals of Hematology (2014)

    Fulltext@MSK | Save
  • Role of CD30 targeting in malignant lymphoma
    Journal Article

    Kumar, A.; Younes, A.
    Current Treatment Options in Oncology (2014)

    Fulltext@MSK | Save